→
DENTSPLY SIRONA Inc's stock is currently priced at $10.07, down from a previous close of $10.41, representing a decline of 3.27%. The company has reported a negative revenue growth of 1.02% YoY, and a troubling ROE of -41.21%, indicating significant financial challenges. With a market cap of $2.44B and a P/S ratio of 0.55, the valuation suggests the stock is undervalued, but the consistent misses in earnings forecasts (e.g., Q1 2026 actual earnings of $0.27 vs. estimates of $0.285) raise concerns about future profitability.
Investors should consider selling XRAY shares until there are signs of recovery in earnings and revenue growth.
If DENTSPLY can successfully leverage its investments in digital dentistry and AI, there is potential for a turnaround. The company has a strong dividend yield of 5.50%, which may attract income-focused investors despite current financial struggles.
Continued earnings misses, such as the $0.27 EPS in Q1 2026 compared to estimates of $0.285, reflect operational inefficiencies. Additionally, the company's ROE of -41.21% indicates severe difficulties in generating shareholder returns, which could lead to further stock depreciation.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates XRAY as Bearish. Investors should consider selling XRAY shares until there are signs of recovery in earnings and revenue growth.
Continued earnings misses, such as the $0.27 EPS in Q1 2026 compared to estimates of $0.285, reflect operational inefficiencies. Additionally, the company's ROE of -41.21% indicates severe difficulties in generating shareholder returns, which could lead to further stock depreciation.
If DENTSPLY can successfully leverage its investments in digital dentistry and AI, there is potential for a turnaround. The company has a strong dividend yield of 5.50%, which may attract income-focused investors despite current financial struggles.
DENTSPLY SIRONA Inc's stock is currently priced at $10.07, down from a previous close of $10.41, representing a decline of 3.27%. The company has reported a negative revenue growth of 1.02% YoY, and a troubling ROE of -41.21%, indicating significant financial challenges. With a market cap of $2.44B and a P/S ratio of 0.55, the valuation suggests the stock is undervalued, but the consistent misses in earnings forecasts (e.g., Q1 2026 actual earnings of $0.27 vs. estimates of $0.285) raise concerns about future profitability.
DENTSPLY SIRONA Inc's stock is currently priced at $10.07, down from a previous close of $10.41, representing a decline of 3.27%. The company has reported a negative revenue growth of 1.02% YoY, and a troubling ROE of -41.21%, indicating significant financial challenges. With a market cap of $2.44B and a P/S ratio of 0.55, the valuation suggests the stock is undervalued, but the consistent misses in earnings forecasts (e.g., Q1 2026 actual earnings of $0.27 vs. estimates of $0.285) raise concerns about future profitability. Our overall verdict is Bearish.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for XRAY at helmterminal.dev/analyze/XRAY, updated continuously during US market hours. No signup required.